Murine Gammaherpesvirus 68 Efficiently Infects Myeloid Cells Resulting In An Atypical, Restricted Form Of Infection.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
29 Jun 2023
Historique:
pubmed: 10 7 2023
medline: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

The gammaherpesviruses (γHVs) establish a lifelong infection in their hosts, with the cellular outcome of infection intimately regulated by target cell type. Murine gammaherpesvirus 68 (MHV68), a small animal model of γHV infection, infects macrophages in vivo, resulting in a range of outcomes, from lytic replication to latent infection. Here, we have further investigated the nature of MHV68 macrophage infection using reductionist and primary in vivo infection studies. While MHV68 readily infected the J774 macrophage cell line, viral gene expression and replication were significantly impaired relative to a fully permissive fibroblast cell line. Lytic replication only occurred in a small subset of MHV68-infected J774 cells, despite the fact that these cells were fully competent to support lytic replication following pre-treatment with interleukin-4, a known potentiator of replication in macrophages. In parallel, we harvested virally-infected macrophages at 16 hours after MHV68 infection

Identifiants

pubmed: 37425871
doi: 10.1101/2023.06.21.545948
pmc: PMC10327065
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA046934
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157201
Pays : United States

Auteurs

Gabrielle Vragel (G)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Brittany D Gomez (BD)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Rachael E Kostelecky (RE)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Kyra S Noell (KS)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.
Department of Anesthesiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Ashley Tseng (A)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.
Department of Anesthesiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Shirli Cohen (S)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Manaal Dalwadi (M)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Eva M Medina (EM)

Department of Neurology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Elizabeth A Nail (EA)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Andrew Goodspeed (A)

Department of Pharmacology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.
University of Colorado Cancer Center, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Eric T Clambey (ET)

Department of Anesthesiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Linda F van Dyk (LF)

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA.

Classifications MeSH